Search
for
Sort by
Research 481–510 of 487
- Discoid lupus erythematosus successfully treated with deucravacitinib
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Possibilities and Limitations for Reversal of Age-Related Hair Loss
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Efficacy and safety of bicalutamide in female hair loss: a review of the literature
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Incidence of acneform reactions after laser hair removal
- Skin reactions caused by epidermal growth factor receptor inhibitors and their management
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Skin toxicity of anti‐cancer therapy
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Prophylaxis and Management of Skin Toxicities
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Drug-Induced Skin, Nail and Hair Disorders
- Dermatologic Reactions to Targeted Therapy
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Cutaneous Toxicities From Transplantation-Related Medications
- Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839
- When bugs and drugs conspire: driving acneiform skin toxicity
- Cutaneous Reactions to Drugs
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Cyclophosphamide-associated acneiform drug eruption in a patient with multiple myeloma
- Cetuximab Induced Hidrocystomas: A Case Report
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Treatment of acne with intermittent isotretinoin, cohort study